Classification of drugs for evaluating drug interaction in drug development and clinical management
Author:
Funder
Japan Agency for Medical Research and Development
Ministry of Health, Labour and Welfare
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference125 articles.
1. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety;Page;Int J Med Inf,2017
2. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process;Huang;J Clin Pharmacol,2008
3. Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs;Okuda;Drug Metab Dispos,1997
4. The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling;Kato;Pharm Res (N Y),2008
5. Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling;Min;Arch Pharm Res (Seoul),2017
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Concomitant Use of Oral Anticoagulants with Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events;Clinical Pharmacology & Therapeutics;2024-09-11
2. Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study;Journal of Pharmaceutical Health Care and Sciences;2024-09-03
3. Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data;BMC Pharmacology and Toxicology;2024-09-03
4. An open‐label study to explore the optimal design of CYP3A drug–drug interaction clinical trials in healthy Chinese people;Pharmacology Research & Perspectives;2024-07-28
5. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series;Journal of Pharmaceutical Health Care and Sciences;2024-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3